Breaking News Instant updates and real-time market news.

MDT

Medtronic

$90.19

0.6 (0.67%)

07:32
05/07/19
05/07
07:32
05/07/19
07:32

Medtronic announces primary endpoint results of Vectors study

Medtronic announced primary endpoint results of the Vectors post market clinical study that demonstrated pain relief and improved function in patients with chronic intractable back and leg pain treated with spinal cord stimulation, or SCS, utilizing the EvolveSM workflow. Medtronic offers the Evolve workflow to help physicians balance high-dose, or HD, and low-dose, or LD, therapy settings on Medtronic SCS systems, including the Intellis platform. Results were presented at the American Society of Interventional Pain Physicians, or ASIPP, annual meeting and found that patients experienced a statistically significant and clinically meaningful improvement with 69% of patients experiencing greater than 50% improvement in overall pain and 70% achieving a personal activity goal at three months. Ninety percent of study subjects had a successful screening trial. One-hundred-three were then implanted with the device, and 98 patients completed the primary endpoint visit. Data from the study demonstrated sustained pain relief, improved quality of life and decreased disability after device implant. Overall: 69% of patients had at least a 50% improvement in overall pain, 70% of patients achieved a personal activity goal, 81% of patients were satisfied with their therapy and 65% improved at least one disability category in the Oswestry Disability Index. The prospective, single-arm, multicenter Vectors study was designed to provide evidence for the Evolve workflow by assessing the effectiveness and potential patient benefits of SCS while having access to both HD and LD stimulation modalities.

  • 08

    May

  • 18

    May

  • 29

    May

MDT Medtronic
$90.19

0.6 (0.67%)

03/18/19
ADAM
03/18/19
NO CHANGE
Target $215
ADAM
Buy
Edwards Lifesciences price target raised to $215 from $190 at Canaccord
Canaccord analyst Jason Mills maintained a Buy rating on Edwards Lifesciences (EW) and raised his price target to $215 from $190 after the PARTNER 3 trial delivered superiority to surgery. In a research note to investors, Mills says he thinks the data will give Edwards a definitive marketing advantage in the TAVRmarket, relative to both Medtronic (MDT) and Boston Scientific (BSX), he thinks now has a higher hurdle to clear in TAVR than pre-Phase 3 data release.
03/18/19
WELS
03/18/19
NO CHANGE
Target $202
WELS
Outperform
Edwards Lifesciences price target raised to $202 from $188 at Wells Fargo
Wells Fargo analyst Lawrence Biegelsen raised his price target for Edwards Lifesciences to $202 from $188 after the results of the company's low-risk TAVR trial was presented at the 2019 American College of Cardiology meeting. The analyst sees potential upside to his forecast given the strong low-risk results presented at ACC. Biegelsen reiterates an Outperform rating on the shares.
03/29/19
STFL
03/29/19
NO CHANGE
Target $45
STFL
Buy
IntriCon added to Select List at Stifel
Stifel analyst Jonathan Block said "the past twelve months have certainly been eventful" for IntriCon (IIN) but he contends that the company is "in a much more formidable place than where they were 12 months ago." In terms of potential catalysts over the next twelve months, Block points to a formalization of the company's contract with Medtronic (MDT), changes to the board, the international rollout of 670G and his expectation for a more aggressive Guardian CGM launch in mid-2019. Block, who believes the stock can double from current levels, added IntriCon to the Stifel Select List and keeps a Buy rating and $45 price target on the shares.
04/09/19
SPHN
04/09/19
NO CHANGE
Target $170
SPHN
Overweight
Medtronic outcomes-based program could be headwind for DexCom, says Stephens
After Medtronic (MDT) announced that the company has reached a deal with Blue Cross and Blue Shield of Minnesota on an outcomes-based program for the company's Guardian Connect Continuous Glucose Monitoring system, Stephens analyst Chris Cooley said the program could potentially represent an incremental headwind to Dexcom's (DXCM) revenue growth if applied across a larger setting. However, Cooley is maintaining his calendar 2019 and 2020 estimates for Dexcom and keeps an Overweight rating on shares with a $170 price target.

TODAY'S FREE FLY STORIES

AEL

American Equity

$27.51

0.3 (1.10%)

17:33
06/20/19
06/20
17:33
06/20/19
17:33
Hot Stocks
American Equity director Debra Richardson sells almost $2.2M in company shares »

American Equity director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$43.68

-0.13 (-0.30%)

17:28
06/20/19
06/20
17:28
06/20/19
17:28
Earnings
Sealed Air backs FY19 adjusted EPS view $2.65-$2.75, consensus $2.73 »

Sealed Air continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$43.68

-0.13 (-0.30%)

17:27
06/20/19
06/20
17:27
06/20/19
17:27
Hot Stocks
Sealed Air names James Sullivan as new CFO, effective June 24 »

Sealed Air announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJRD

Aerojet Rocketdyne

$43.01

1.49 (3.59%)

17:27
06/20/19
06/20
17:27
06/20/19
17:27
Hot Stocks
Aerojet Rocketdyne subsidiary awarded $140.18M missile defense modification »

Coleman Aerospace, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$43.68

-0.13 (-0.30%)

17:25
06/20/19
06/20
17:25
06/20/19
17:25
Hot Stocks
Sealed Air terminates CFO William Stiehl for cause, effective immediately »

Sealed Air announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBU

Brookfield Business Partners

$41.25

1.28 (3.20%)

, BAM

Brookfield

$48.38

0.29 (0.60%)

17:15
06/20/19
06/20
17:15
06/20/19
17:15
Syndicate
Brookfield Business Partners announces $795M equity offering »

Brookfield Business…

BBU

Brookfield Business Partners

$41.25

1.28 (3.20%)

BAM

Brookfield

$48.38

0.29 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

AXLA

Axcella

$10.39

0.27 (2.67%)

17:13
06/20/19
06/20
17:13
06/20/19
17:13
Earnings
Axcella reports Q1 EPS ($2.43), consensus (49c) »

Q1 operating expenses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LKSD

LSC Communications

$5.83

0.07 (1.22%)

17:11
06/20/19
06/20
17:11
06/20/19
17:11
Hot Stocks
LSC comments on DOJ action regarding proposed transaction with Quad »

LSC Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QUAD

Quad/Graphics

$9.75

0.09 (0.93%)

, LKSD

LSC Communications

$5.83

0.07 (1.22%)

17:10
06/20/19
06/20
17:10
06/20/19
17:10
Hot Stocks
Quad/Graphics intends to defend proposed LSC Communications acquisition »

Quad/Graphics (QUAD)…

QUAD

Quad/Graphics

$9.75

0.09 (0.93%)

LKSD

LSC Communications

$5.83

0.07 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFM

Sprouts Farmers Market

$19.52

0.14 (0.72%)

17:04
06/20/19
06/20
17:04
06/20/19
17:04
Hot Stocks
Sprouts Farmers Market interim co-CEO/CFO Brad Lukow resigns »

Sprouts Farmers Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NAKD

Naked Brand Group

$0.27

0.0025 (0.93%)

17:03
06/20/19
06/20
17:03
06/20/19
17:03
Syndicate
Breaking Syndicate news story on Naked Brand Group »

Naked Brand Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$20.85

0.22 (1.07%)

16:57
06/20/19
06/20
16:57
06/20/19
16:57
Hot Stocks
HP Inc. General Counsel sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 01

    Jul

  • 02

    Jul

  • 03

    Jul

  • 04

    Jul

CPT

Camden Property

$107.61

0.57 (0.53%)

16:54
06/20/19
06/20
16:54
06/20/19
16:54
Hot Stocks
Camden Property COO sells 16.2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COMM

CommScope

$16.00

0.38 (2.43%)

16:52
06/20/19
06/20
16:52
06/20/19
16:52
Hot Stocks
CommScope's distributed antenna system patents upheld in favorable ruling »

CommScope received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

INVH

Invitation Homes

$27.68

-0.07 (-0.25%)

16:50
06/20/19
06/20
16:50
06/20/19
16:50
Syndicate
Invitation Homes announces offering of 37.5M shares of common stock for holders »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGY

VAALCO Energy

$1.55

0.03 (1.97%)

16:46
06/20/19
06/20
16:46
06/20/19
16:46
Hot Stocks
VAALCO Energy announces $10M stock buyback program »

VAALCO Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTG

Entegris

$38.50

1.36 (3.66%)

, INTC

Intel

$47.16

0.08 (0.17%)

16:45
06/20/19
06/20
16:45
06/20/19
16:45
Initiation
Entegris, Intel, TSMC initiated  »

Entegris initiated with a…

ENTG

Entegris

$38.50

1.36 (3.66%)

INTC

Intel

$47.16

0.08 (0.17%)

TSM

TSMC

$40.52

1.11 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

16:38
06/20/19
06/20
16:38
06/20/19
16:38
General news
Money Supply M2 Weekly Change data reported »

Week of 6/10 Money Supply…

LH

LabCorp

$168.01

-1.54 (-0.91%)

16:37
06/20/19
06/20
16:37
06/20/19
16:37
Upgrade
LabCorp rating change at Deutsche Bank »

LabCorp upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

FNKO

Funko

$24.25

2.02 (9.09%)

16:35
06/20/19
06/20
16:35
06/20/19
16:35
Initiation
Funko initiated  »

Funko initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

HSIC

Henry Schein

$70.96

-1.06 (-1.47%)

16:35
06/20/19
06/20
16:35
06/20/19
16:35
Hot Stocks
Henry Schein CFO Steven Paladino sells almost $1.5M in company shares »

Henry Schein CFO Steven…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:34
06/20/19
06/20
16:34
06/20/19
16:34
General news
Fed Balance Sheet Level data reported »

Week of 6/19 Fed Balance…

CTRV

ContraVir Pharmaceuticals

$4.27

-0.485 (-10.21%)

16:34
06/20/19
06/20
16:34
06/20/19
16:34
Hot Stocks
ContraVir Pharma receives positive FDA response to NASH candidate plans »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTX

Minerals Technologies

$59.21

0.34 (0.58%)

16:31
06/20/19
06/20
16:31
06/20/19
16:31
Hot Stocks
Minerals Technologies initiates restructuring program through staff cuts »

Minerals Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/20/19
06/20
16:30
06/20/19
16:30
Options
Preliminary option volume of 26.6M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.